PODD
HOLD / NEUTRALMeanRevComposite
45.60
Technical
16.70
Fundamental
55.20
Rank
—
Price
145.42
Hurst
0.27
As of
Aug 25, 2026
Daily
Insulet Corporation
HealthcareMedical DevicesInsulet Corporation manufactures and distributes insulin delivery systems for diabetes patients globally, with its primary Omnipod platform offering multiple versions including an automated system that syncs with continuous glucose monitors via Bluetooth, and a smartphone-controlled pod model. The company also produces drug delivery pods for Amgen's chemotherapy support product and sells through pharmacies and independent distributors.
Market cap
$9.8B
P/E (trailing)
26.41
P/E (forward)
18.36
PEG ratio
1.11
Dividend yield
—
Beta
1.08
52w range
126.40 – 354.88
Return on equity
+26.02%
Profit margin
+12.29%
Revenue growth
+23.50%
Earnings growth
+328.60%
Price history
1Y: 141.55 (-57.6%) · range 131.96–346.36
Cycle position
19/ 100 cycle scoreENTRY ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 64 · MODERATE · exit proximity 0
Conviction
37/ 100 · maturity 100%
VScore.4012
Buildup.2039
EMA entry setup.2564
Fundamentals.1555
Volume profile
POC
143.81
Price vs POC
-1.6%
Overhead supply
84%
Runway
+0.3%
Value area 137.40–164.89 · 84% of 120d volume overhead · heavy supply
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.033 | Sep 3, 2026 |
| congressional-trading | 0.000 | Sep 17, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -10.92% | +1.65% | 6/20d |
| 40d | -10.92% | +1.65% | 6/40d |